In a first-of-its-kind product, a new line of instant release CBD tablets combines compounded cannabinoid ingredients in precise formulations utilizing the patent-pending technology of Volunteer Botanicals. Prolifera Instant Release Tablets create combinations of CBD and minor cannabinoids that replace the oil-based unpleasantness of typical CBD products with a familiar form factor that makes maintaining a CBD wellness regimen as easy as taking a daily vitamin.

“The future of cannabinoids is here,” said Justin Hamilton, CEO of Hempleton Investment Group, which co-developed the products with Volunteer Botanicals. “Prolifera hemp-derived cannabinoid tablets are engineered with pharmaceutical technology that produces a consistent, instant-release dose of CBD and a boosted dose of minor cannabinoids to help amplify CBD benefits. When we discovered how Volunteer Botanicals’ technology could compound cannabinoids into easy-to-ingest, familiar form factors, we knew we had to work together. This is how we integrate CBD and minor cannabinoids into people’s everyday regimens.”

The innovative suite of products from Hempleton Investment Group is made possible through Volunteer Botanicals’ Lipid Neutralization System (LNS), which creates miscible and “flowable” cannabinoid ingredients that can be combined to create precise formulations in traditional consumer-friendly products. Prolifera Instant Release Tablets are available in three, 50mg formulations:

• CBD+Terpenes Instant Release Tablets (50mg CBD)
• CBD+CBG Instant Release Tablets (25mg CBD, 25mg CBG)
• CBD+CBN Instant Release Tablets (38mg CBD, 12mg CBN)

Each Prolifera Instant Release Tablet is color coded per its minor cannabinoid formulation.  This allows customers to easily break the scored 50mg tablets into two 25mg sections, which they can combine even further with other cannabinoid tablets to create the desired formulation that meets their individual needs. Consumers no longer need to worry if inconsistent tincture drops or poorly formulated gel capsules are meeting their needs. Plus, the distaste and oddity of consuming an oil-based “medicine” is eliminated.

“This is a CBD and cannabinoid delivery form that consumers understand and is easily integrated into their existing wellness regimen,” said Derek Odette, CEO of Volunteer Botanicals. “It is exactly what we have been working toward as we perfected the Lipid Neutralization System. We are seeing the day when the compounds of the hemp and cannabis plants can be effectively isolated, reformulated and recombined with other cannabinoids, nutritional supplements or even pharmaceuticals. The opportunities to create new wellness and health solutions are endless.”